News

Servier and PRISM BioLab enter drug discovery collaboration for a novel target

PRISM BioLab provides PepMetics® (peptide mimetic small molecules) Technology for generating Hit and Lead compounds against Servier’s novel target.

Read Full Press Release

Scroll to top
en_USEnglish